These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 28758845

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
    Phillip Lee YH, Sathigari S, Jean Lin YJ, Ravis WR, Chadha G, Parsons DL, Rangari VK, Wright N, Babu RJ.
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
    [Abstract] [Full Text] [Related]

  • 23. Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata.
    Inoue Y, Yoshino K, Kudo S, Kodama N, Moteki H, Kimura M.
    J Pharm Pharm Sci; 2024 Sep; 27():13230. PubMed ID: 39193564
    [Abstract] [Full Text] [Related]

  • 24. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state.
    Jug M, Mennini N, Kövér KE, Mura P.
    J Pharm Biomed Anal; 2014 Mar; 91():81-91. PubMed ID: 24444785
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system.
    Shah M, Karekar P, Sancheti P, Vyas V, Pore Y.
    Drug Dev Ind Pharm; 2009 Jan; 35(1):118-29. PubMed ID: 18979307
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B, Zhong S, Li N, Li X, Yi J, Jin M.
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
    Mummidi V, Jayanthi V.
    Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
    Orienti I, Cerchiara T, Zecchi V, Arias Blanco MJ, Gines JM, Moyano JR, Rabasco Alvarez AM.
    Int J Pharm; 1999 Nov 15; 190(2):139-53. PubMed ID: 10547454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.